 |
Previous Article | Next Article 
The Journal of Neuroscience, February 1, 1999, 19(3):1049-1061
Purification and Characterization of Astrocyte Precursor Cells in
the Developing Rat Optic Nerve
Huaiyu
Mi and
Ben A.
Barres
Stanford University School of Medicine, Department of Neurobiology,
Fairchild Science Building, Stanford, California 94305-5125
 |
ABSTRACT |
The signaling interactions that control oligodendrocyte generation
from their precursor cells have been studied intensively. Much less is
known about how astrocyte generation is normally controlled. Here we
report the purification and characterization of astrocyte precursor
cells (APCs) from the developing rat optic nerve. APCs are
antigenically distinct from astrocytes. Both cell types are
Pax2+ and vimentin+, whereas
astrocytes are GFAP+ and S100 +, and
the precursor cells are A2B5+. In contrast to
purified astrocytes, purified APCs rapidly die in serum-free culture
but can be saved by basic fibroblast growth factor (bFGF) and glial
growth factor 2 (GGF2). Unlike oligodendrocyte precursor cells,
APCs do not differentiate by default; their differentiation into
GFAP+ cells is induced by ciliary neurotrophic
factor (CNTF) or by leukemia inhibitory factor (LIF). Finally,
the survival, proliferation, and differentiation of APCs were promoted
by coculture with other embryonic optic nerve cell types but not with
purified embryonic retinal ganglion cells, indicating that interactions
with non-neuronal cells are likely to play an important role in
controlling astrocyte generation in the developing optic nerve.
Key words:
glial development; survival; proliferation; differentiation; glial growth factor (GGF); basic fibroblast growth
factor (bFGF); ciliary neurotrophic factor (CNTF); leukemia inhibitory
factor (LIF)
 |
INTRODUCTION |
Although much recent progress has
been made in understanding the development of oligodendrocytes and
Schwann cells, much less is known about astrocyte development. There
are two main types of astrocytes. Protoplasmic astrocytes are located
in the gray matter and have end feet that contact synapses and blood
vessels. Fibrous astrocytes are located in the white matter and have
end feet that contact nodes of Ranvier and blood vessels (Peters et al., 1991 ). These two astrocyte types may have a different lineage. Some protoplasmic astrocytes are generated by multipotent
subventricular zone progenitor cells (Levison and Goldman, 1993 ;
Zerlin et al., 1995 ), whereas some fibrous astrocytes are generated by
radial glia (Choi and Lapham, 1978 ; Schmechel and Rakic, 1979 ; Misson et al., 1988 ; Voigt, 1989 ; Goldman, 1996 ). The generation of astrocytes from multipotent neural stem cells in culture is induced by bone morphogenic factors (BMPs), ciliary neurotrophic factor (CNTF), and
basic fibroblast growth factor (bFGF) (Gross et al., 1996 ; Johe et al.,
1996 ; Bonni et al., 1997 ; Qian et al., 1997 ). There is some evidence
that precursor cells committed to the astrocyte lineage exist
(Fok-Seang and Miller, 1992 ; Davis and Temple, 1994 ; Qian et al.,
1998 ), but it is not known how they are signaled to survive,
proliferate, and differentiate.
The developing rat optic nerve has served as a simple model system for
studies of cell-cell interactions that control glial development (Raff
et al., 1983 ; Barres et al., 1992 ; Raff, 1989 ). The optic nerve is part
of central white matter and, in addition to the axons of retinal
ganglion cells, contains the same glial cell types found in white
matter throughout the CNS. Previous studies have provided
evidence of two different glial lineages that develop within the nerve
(Raff et al., 1984 ; Miller et al., 1985 , 1989 ; Skoff, 1990 ). Type-1
astrocytes develop embryonically (Raff et al., 1984 ; Miller et al.,
1985 , 1989 ), whereas oligodendrocytes develop postnatally (Raff et al.,
1983 ; Miller et al., 1985 ). The oligodendrocytes are generated by
oligodendrocyte precursors cells (OPCs, also termed O-2As for
oligodendrocyte type-2 astrocyte precursor cell) (Raff et al., 1983 ).
It has been proposed that the type-1 astrocytes are generated by
RAN-2+ GFAP cells
because these cells are the major cell type in embryonic day 16 (E16)
optic nerve and because type-1 astrocytes are also RAN-2+ (Raff et al., 1984 ). Type-2 astrocytes
are a major astrocytic component in postnatal optic nerve cultures that
are generated by OPCs cultured in the presence of fetal calf serum but
are not presently thought to exist in vivo (Fulton et al.,
1992 ).
Our understanding of the development of oligodendrocytes and Schwann
cells has been assisted greatly by the identification, purification,
and characterization in culture of Schwann cell precursor cells (Jessen
and Mirsky, 1997 ) and oligodendrocyte precursor cells (Raff,
1989 ; Barres and Raff, 1994 ). Here we describe a method to purify
astrocyte precursor cells (APCs) from the developing rat optic nerve.
We purified APCs from embryonic rat optic nerve to >95% purity by a
sequential immunopanning procedure and characterized their antigenic
and developmental properties in vitro. We found that the
Pax2 transcription factor is expressed specifically by all astrocyte
lineage cells in the optic nerve throughout their development and not
by oligodendrocytes or other cell types. APCs are
GFAP , S100 ,
A2B5+, and Pax2+, whereas optic
nerve astrocytes are GFAP+, S100 +,
A2B5 , and Pax2+. Unlike
astrocytes, purified APCs die in serum-free culture but can be
stimulated to survive and divide by bFGF or by glial growth factor
2 (GGF2). In addition, purified APCs do not differentiate constitutively in serum-free culture but are induced to differentiate into GFAP+ astrocytes by CNTF or by leukemia
inhibitory factor (LIF). Finally, the survival, proliferation, and
differentiation of APCs is promoted by signals from other optic nerve
cell types.
 |
MATERIALS AND METHODS |
Detailed step-by-step protocols for all procedures are available
on request (barres{at}stanford.edu).
Reagents. Recombinant human trophic factors were obtained
from Peprotech (bFGF), Cambridge Neuroscience (GGF2), Regeneron (CNTF),
and R & D Systems (Minneapolis, MN; LIF). Monoclonal antibodies were
obtained from Serotec (Indianapolis, IN; MRC-OX7 anti-Thy1.1 IgG
antibody), American Type Culture Collection (Rockville, MD; A2B5), Jim
Cohen (C5 neuroepithelial antibody), Developmental Hybridoma Bank
(RAT401 anti-nestin antibody), Sigma (St. Louis, MO; anti-S100
antibody), Barbara Ranscht [Rmab anti-galactocerebroside (anti-GC) antibody], Ursula Drager (R5 anti-vimentin
antibody), and Boehringer Mannheim [Indianapolis, IN;
anti-5-bromo-2'-deoxyuridine (BrdU) antibody]. Polyclonal
antibodies were obtained from Babco (Richmond, CA; rabbit anti-Pax2
antiserum) and Dako (Carpinteria, CA; rabbit anti-GFAP antiserum).
Preparation of optic nerve cell suspension. Sprague Dawley
rats (Simonson Labs) were used for all experiments. The date of plugging was E0. All embryos were examined to verify their ages, and
obviously overage embryos were discarded.
Embryonic and postnatal optic nerves were dissected and enzymatically
dissociated using papain as described previously (Barres et al., 1992 ).
In brief, minced optic nerves were incubated at 37°C for 45 min
[postnatal day 1 (P1)] or 30 min (E16-E19) in a papain solution (33 U/ml; Worthington, Freehold, NJ) in Dulbecco's PBS (DPBS) (Life
Technologies, Gaithersburg, MD) containing L-cysteine (0.4 mg/ml) and DNase (125 units/ml). The tissues were then triturated sequentially in a solution containing ovomucoid (2 mg/ml), DNase (125 units/ml), and BSA (1 mg/ml) to yield a suspension of single cells. The
cells were recovered by centrifugation at 1000 × g. On
average, ~13,000 or 15,000 cells were obtained from each E17 or P1
optic nerve, respectively.
Purification of astrocytes and their precursor cells by
sequential immunopanning. Optic nerve astrocytes from P1 rats were purified by sequential immunopanning as described previously (Barres et
al., 1994 ). In brief, cell suspensions were incubated first on a
panning dish coated with the MRC-OX7 anti-Thy1.1 antibody to deplete
microglia and meningeal cells and then on a second dish coated with the
A2B5 antibody to deplete OPCs. The remaining neuroepithelial cells were
selected on the final dish coated with the C5 anti-neuroepithelial
antibody (Miller et al., 1984 ). None of the A2B5+
cells depleted from the P1 (or older) suspensions had the phenotype of
APCs that were only present embryonically (see Results). Astrocyte precursor cells were purified from E17 embryonic optic nerves by a
similar procedure except that the A2B5 dish was omitted because almost
no OPCs have migrated into the optic nerve by E17. (We did not purify
APCs from E18 to E21 nerves, but this could be accomplished simply by
using an O4 dish instead of the A2B5 dish so that OPCs but not APCs
would be depleted.) The purified cells were recovered by trypsin
digestion from the panning dish for further experiments. An average of
~5000 precursor cells or 4000 astrocytes was obtained from each E17
or P1 optic nerve, respectively. This represented a yield of >90% of
the precursor cells and astrocytes present in the cell suspensions that
had survived the optic nerve dissociation procedure.
Culture of astrocytes and their precursor cells.
Approximately 5000 purified astrocytes or their precursor cells were
plated in 10 µl of medium onto a 24 well culture dish (Falcon) or
onto 1.2 cm glass coverslips (Marienfeld), both of which were
precoated with poly-D-lysine (70 kDa; 10 µl/ml; Sigma)
and cultured for 10-15 min. This preplating procedure is necessary to
ensure the attachment of most of the cells to the culture dishes or
coverslips. The cells were then cultured in 500 µl of Bottenstein and
Sato (B-S) serum-free medium [modified from Bottenstein and Sato
(1979) as described previously (Lillien et al., 1990 )],
including the additives sodium pyruvate (1 mM), glutamine
(1 mM), penicillin-streptomycin (100 units/ml),
N-acetyl-cysteine (60 mg/ml), and hydrocortisone (10 µM) and the appropriate trophic factors. In some cases,
as indicated in the Results, chlorphenylthio-cAMP (CPT-cAMP; 125 µM) was added. Peptide trophic factors were used at the
following levels: 10 ng/ml for bFGF, 50 ng/ml for GGF2, 10 ng/ml for
CNTF, 10 ng/ml for LIF, and 5 µg/ml for insulin. In some
experiments, as indicated in the Results, APCs were cultured in B-S
serum-free medium with insulin, CPT-cAMP, and bFGF for 1 hr and were
washed in B-S serum-free medium three times and then cultured in the appropriate media. The cells for BrdU assays were fed daily to supplement the factors. The initial percentage of GFAP-positive cells
was assessed by immunostaining after 1 hr of culture. The initial
viability was usually assessed by the MTT assay 1-3 hr after plating
(see below) and typically was over 90%.
Coculture of APCs with mixed optic nerve cells or retinal
ganglion cells. E17 mixed optic nerve cells were prepared by
digesting optic nerves for 30 min in 0.125% trypsin solution, followed
by trituration in DPBS with 10% FCS; 25,000-30,000 mixed cells were plated in each well of a 24 well culture plate with 500 µl of B-S
serum-free medium containing no peptide trophic factors except those
indicated for survival assays or containing insulin and CPT-cAMP for
proliferation and differentiation assays, as indicated. E19 RGCs
were prepared according to the procedure described previously (Meyer-Franke et al., 1995 ). Approximately 40,000 retinal ganglion cells (RGCs) were plated in each well with 500 µl of B-S serum-free medium supplemented with BDNF (10 ng/ml), B27 (1:50; Life
Technologies), T3 (30 nM), and CPT-cAMP (125 µM). Two days later, 5000 APCs that had been preplated
onto glass coverslips were added to the above cultures suspended over
the optic nerve cells by glass chips, and another 500 µl of the
appropriate medium was added. Cells were fed every other day.
MTT survival assay. Approximately 5000 cells were plated per
well into 24 well culture dishes (Falcon) and cultured for 3 d,
and the percentage of surviving cells was assessed by the MTT assay as
described previously (Mosmann, 1983 ; Meyer-Franke et al., 1995 ). All
values are given as the mean ± SD of triplicates (unless
otherwise mentioned) in one experiment. All experiments were repeated
one or more times as indicated.
BrdU assay. To label cells in S phase in vivo, we
injected BrdU (0.1 mg/gm of body weight in a DPBS solution; Boehringer
Mannheim) intraperitoneally into the pregnant mother (for
embryos) or perinatal rats. After 2 hr, the animals were killed, and
the optic nerves were dissected, fixed, sectioned, and double
immunostained by anti-BrdU and anti-Pax2 antibodies (see below).
To label cells in S phase in vitro, we added BrdU (10 µg/ml), which is incorporated into replicating DNA, to the cultures for 2 hr, followed by fixation and staining with a BrdU antibody (see below).
Cryosection of optic nerves. Optic nerves were dissected and
fixed in ice-cold 4% paraformaldehyde for 1 hr and then infiltrated with 30% sucrose overnight at 4°C. To label cells in S phase
in vivo, we injected BrdU into pregnant or perinatal animals
as described above. The animals were killed after 2 hr, and their optic
nerves were fixed and cryoprotected as described above. The nerves were then sectioned longitudinally into 8-µm-thick cryosections that were
collected on precoated slides (Sigma) and placed at room temperature
for 30 min to air dry. The sections were stored at 80°C until staining.
Immunofluorescence staining. The cryosections were baked at
50°C for 15 min to ensure the attachment of tissues to the slides. After fixation with 4% paraformaldehyde for 10 min at room temperature and a 30 min incubation in blocking buffer (50% normal goat serum solution containing 150 mM NaCl, 50 mM Tris, pH
7.4, 1% BSA, 100 mM L-lysine, and 0.2% Triton
X-100) to block nonspecific binding, the cryosections of optic nerves
were stained with the polyclonal Pax2 antiserum overnight, washed, and
then incubated for 1 hr in a fluorescein-coupled goat anti-rabbit IgG
antibody (Jackson Lab). For the BrdU experiments, the optic nerve
sections were incubated in 2N HCl for 10 min to denature the nuclear
DNA, followed by an incubation in 0.1 M sodium borate
(Na2B4O7) for 5 min. The sections were incubated in a blocking buffer containing 50% goat serum
and 0.2% Triton X-100 for 30 min, double stained with the monoclonal
anti-BrdU antibody (Boehringer Mannheim) and polyclonal Pax2 antiserum
(Babco) overnight, and incubated with a fluorescein-coupled goat
anti-rabbit IgG and a Texas Red-conjugated goat anti-mouse IgG antibody
(Jackson Lab) for 1 hr.
Cultured cells on coverslips were treated similarly except a shorter
incubation time was used. The stained sections and cultures were
mounted with Citiflour (Chemistry Lab, University of Kent, UK) and
sealed with nail polish. A Nikon Microphot-FXA microscope was used to
observe and photograph the fluorescence staining.
 |
RESULTS |
Purification of optic nerve astrocytes and their
precursor cells
To determine when astrocyte generation begins in the optic nerve,
we immunostained cryosections of optic nerves at various ages with an
anti-GFAP antibody. There was little detectable signal in E17 optic
nerve, except for occasional immunoreactivity near the pia (Fig.
1A). GFAP staining
could be detected throughout the P1 (Fig. 1B) and
adult optic nerve (data not shown). Because few astrocytes have
developed at E17 and it is difficult to dissect out nerves before this
age, we purified astrocyte precursor cells from E17 optic nerves.

View larger version (70K):
[in this window]
[in a new window]
|
Figure 1.
The appearance of GFAP immunoreactivity in the
developing rat optic nerve. Optic nerves from embryonic day 17 (A) and postnatal day 1 (B) rats were fixed, sectioned longitudinally,
and stained with an anti-GFAP antibody. GFAP expression was scarcely
detected in E17 optic nerve
(A) but was found throughout the
P1 optic nerve (B). Scale bar, 50 µm.
|
|
Astrocyte lineage cells were purified from optic nerves of P1 and E17
rats by a sequential immunopanning procedure (see Materials and
Methods). In brief, astrocytes were purified by sequential panning of a
P1 optic nerve cell suspension on three Petri dishes coated with a
monoclonal anti-Thy1.1 antibody to deplete microglia, which adhere via
their Fc receptors to the first antibody-coated dish on which they are
incubated, and meningeal fibroblasts, with the monoclonal A2B5 antibody
to deplete OPCs (Raff et al., 1983 ), and with a monoclonal C5
anti-neuroepithelial cell antibody to select astrocyte lineage cells
(Miller et al., 1984 ). For purification of astrocyte precursor cells
from E17 optic nerve, the Petri dish coated with the A2B5 antibody was
omitted because there are no OPCs in the optic nerve at that age.
Astrocytes were purified from P1 optic nerves to >99% purity by this
method, as assessed by staining with a GFAP antibody immediately after
isolation (Fig. 2B,C).
In contrast, there were virtually no GFAP-positive cells at E16 (Fig.
2C), and only 8% of the purified cells were
GFAP+ at E17 (Fig.
2A,C). The number of
GFAP+ cells increased rapidly to 42% at E18 and to
92% at E19 (Fig. 2C).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 2.
GFAP immunoreactivity in purified
astrocytes and their precursor cells. A,
B, Astrocyte lineage cells were purified from
E17 (A) and P1
(B) rat optic nerves by immunopanning.
Left, The cells were cultured for 1 hr and then fixed
and immunostained immediately with an anti-GFAP
antibody. Right, The total cells were viewed by
counterstaining the nuclei with 4,6-diamidino-2-phenylindole
(DAPI). C, The percentage of
GFAP+ cells was determined at various
ages. The results represent means ± SEM of two to five separate
experiments, with triplicates in each experiment. Scale bar, 80 µm.
|
|
To determine whether the GFAP cells purified from
E17 optic nerves with this procedure were astrocyte precursor cells, we cultured the purified cells to see whether they would differentiate into GFAP+ cells. More than 95% of the purified
cells became GFAP+ in response to CNTF or LIF,
indicating that these cells were astrocyte precursor cells (detailed
results of differentiation studies are discussed below). Cells that did
not bind to the C5 dish were collected and cultured in medium
containing CNTF. Less than 1% of these cells became
GFAP+ (data not shown), suggesting that we
successfully purified the majority of astrocyte precursor cells from
our optic nerve suspensions.
Because CNTF also induces A2B5+ OPCs to
differentiate into GFAP+ type-2 astrocytes (Hughes
et al., 1988 ; Lillien et al., 1988 ), we next examined the possibility
that we had purified OPCs instead of APCs. Three lines of evidence
argue against this possibility. First, at E17, almost all OPCs in the
optic nerve are found in the chiasm (Small et al., 1987 ), which is not
included in our optic nerve dissection. Second, when the purified cells
were cultured for 4 d in conditions that would allow OPCs to
differentiate into oligodendrocytes (Raff et al., 1983 ; Barres et al.,
1992 ), no cells could be stained by an anti-GC antibody, a specific
marker of oligodendrocytes. Lastly, the GFAP+ cells
that differentiated from the purified APCs had the typical morphology
of type-1 but not type-2 astrocytes (see below). Therefore, we conclude
that the purified cells were astrocyte precursor cells and not OPCs.
Antigenic characteristics of astrocytes and their
precursor cells
Pax2 is a member of the pax protein transcription factor family
that is characterized by a DNA-binding element called the paired box.
Pax2 has been shown to be expressed by glial-like cells in the
embryonic mouse optic cup, stalk, and nerve (Nornes et al., 1990 ). This
suggested the possibility that Pax2 might be expressed specifically by
astrocyte lineage cells. To examine this possibility, we immunostained
optic nerve sections of different ages with a Pax2 antiserum (Fig.
3). At E17, most cells within the optic
nerves were stained, whereas no cells in the optic chiasm were stained
(Fig. 3A,B). Because most OPCs are
in the chiasm at E17, this finding suggested that it was unlikely that
they express Pax2 (see below). Most of the cells stained by Pax2 were located in the parenchyma of the nerve rather than on the pial surface
(Fig. 3C,D), suggesting that they are likely to
be astrocyte lineage cells. Pax2+ cells in the optic
nerves persisted in perinatal (Fig.
3E,F) and adult (Fig.
3G,H) optic nerves, although the
expression level decreased in older nerves.

View larger version (47K):
[in this window]
[in a new window]
|
Figure 3.
Pax2 immunoreactivity in the
developing rat optic nerve. Longitudinal sections of optic nerves from
E17 (A-D), P8
(E, F), and adult
(G, H) rat were stained with a
Pax2 antiserum (A, C,
E, G) and with DAPI
(B, D, F,
H). Nuclei of cells were labeled by
Pax2 along the length of the E17 optic
nerve (O.N.) but not in the chiasm (A,
B). At higher magnification, only the cells within the
parenchyma of the optic nerve were labeled; the pial cells were not
labeled (arrowheads in C,
D). The Pax2 labeling persisted in the
optic nerve at P8 (E,
F) but became fainter in the adult optic nerve
(G, H). Scale bars:
A, B, E-H,
80 µm; C, D, 33 µm.
|
|
To determine further which cell type was Pax2+,
acutely isolated cells from optic nerves were stained using an
anti-Pax2 antiserum (Fig. 4). At E17,
~50% of the cells were Pax2+ (Fig.
4A). Over 95% of the purified APCs from E17 optic
nerve (C5+ fraction) cells were
Pax2+, whereas only ~2% of the other cells
(C5 ) were stained. Nearly all of the
S100 + astrocytes from P1 and P8 optic nerves were
labeled by Pax2 (Fig. 4B,C), as
were nearly all of the astrocytes purified from P1 optic nerves. No
OPCs purified from P8 optic nerves were stained by Pax2. Thus, Pax2 is
a specific marker for astrocyte lineage cells in the optic nerve and is
present in astrocytes as well as in their precursor cells. Many
Pax2+ S100 APCs were present in
embryonic optic nerve suspensions, but APCs with this phenotype were
not present in P1, P8, or adult optic nerve suspensions.

View larger version (68K):
[in this window]
[in a new window]
|
Figure 4.
Pax2 immunoreactivity in optic
nerve cell suspensions. Optic nerves were dissociated from
E17 (A), P1
(B), and P8
(C) rats and then were double labeled with a
Pax2 antiserum and an S100 monoclonal
antibody. The nuclei were counterstained by DAPI
(left). Many nuclei at all three ages stained with the
Pax2+ antiserum
(middle), and at P1 and
P8, the Pax2 immunoreactivity was
colocalized in cells stained with S100 antibody
(right). Scale bar, 80 µm.
|
|
We next examined the expression of previously reported astrocyte
markers. We immunostained purified populations of astrocyte precursor
cells (E17) and of perinatal astrocytes (P1) with antibodies to these
markers (Table 1). Both anti-GFAP and
anti-S100 antibodies, which are specific markers of astrocytes, did
not stain the APCs. The C5 monoclonal antibody, a marker of
neuroepithelial cells, labeled both astrocytes and their precursors.
Similarly, the RAN-2 monoclonal antibody (Bartlett et al., 1980 )
labeled both astrocytes and APCs as reported previously (Raff et al.,
1984 ). Anti-vimentin antibody (Drager et al., 1984 ) labeled both
precursor cells and astrocytes. Anti-nestin antibody, a marker of many
neural stem cells (Frederiksen and McKay, 1988 ), labeled only some of
the precursor cells as well as the perinatal astrocytes. The A2B5 monoclonal antibody, which in rats is a marker of OPCs as well as a
recently identified multipotent glial precursor cell purified in the
brain (Raff et al., 1983 ; Rao and Mayer-Proschel, 1997 ), lightly
labeled the APCs but not the astrocytes. The A2B5 immunoreactivity on
the APCs, although consistently present, was substantially weaker than
that on OPCs. Thus, APCs have an antigenic phenotype that is
GFAP , S100 ,
A2B5+, and Pax2+, whereas
astrocytes are GFAP+, S100 +,
A2B5 , and Pax2+.
Effects of peptide trophic factors on the survival of astrocyte
precursor cells
To determine whether the purified P1 astrocytes or the E17 APCs
can survive when cultured in B-S serum-free medium (Materials and
Methods) lacking insulin and other peptide trophic factors, we
performed an MTT survival assay after 24, 48, and 72 hr of culture. The
majority of P1 astrocytes survived for 3 d of culture, whereas
most of the E17 APCs died after 48 hr (Fig.
5A) with the typical shrunken
cytoplasmic and nuclear morphology of apoptosis (Fig. 5D).
Astrocytes did die, however, when cultured at clonal density (data not
shown). These findings suggest that the astrocytes make their own
survival signals, whereas the APCs require signals, presumably from
neighboring cells, to survive.

View larger version (62K):
[in this window]
[in a new window]
|
Figure 5.
Survival of purified astrocyte precursor cells in
culture. A, Purified astrocytes (P1) and
their precursor cells (E17) were cultured in
serum-free, insulin-free modified B-S medium in 24 well culture plates
for the times indicated. B, Purified APCs were cultured
for 3 d in the serum-free B-S medium containing forskolin or
CPT-cAMP or in DMEM containing 10% FCS.
C, Purified APCs were cultured in serum-free B-S medium
containing insulin (INS), CPT-cAMP, or
peptide trophic factors as indicated. Survival was determined by the
MTT assay after 72 hr, unless otherwise indicated. The results
represent the means ± SD of three wells in a single experiment
and were repeated in at least three separate experiments.
D, Phase-contrast micrographs of P1
astrocytes and E17 precursor cells in culture are shown.
The purified cells were cultured in medium lacking peptide trophic
factors (None) or with basic FGF, insulin, and
CPT-cAMP (bFGF/INS/CPT-cAMP). Scale bar,
80 µm.
|
|
We next assessed the effects of signals that have been reported to
promote the survival of other neural cell types. To determine whether
elevation of intracellular cAMP levels promotes survival, we cultured
the precursor cells for 3 d in B-S serum-free medium containing
forskolin. Survival was slightly, but significantly, improved (Fig.
5B). Because intracellular cAMP can be degraded by cyclic
nucleotide phosphodiesterases, we also cultured the precursor cells in
CPT-cAMP, a cell membrane-permeable cAMP analog that is resistant to
these phosphodiesterases. APC survival was improved further, to
~40%, but the majority of the cells still died (Fig. 5B).
Surprisingly, when the precursor cells were cultured in medium
containing 10% FCS, although the astrocytes survived as expected,
almost all of the APCs died (Fig. 5B).
We next asked whether peptide trophic factors normally expressed in the
developing optic nerve could promote survival of the astrocyte
precursor cells. Insulin (5 µg/ml), used at a concentration sufficient to activate IGF-1 receptors, promotes survival of many other
cell types including neurons and oligodendrocytes (Barres et al., 1992 ,
1993 ; Meyer-Franke et al., 1995 ). It did not promote, however, the
survival of astrocyte precursor cells (Fig. 5C). GGF2 alone
also showed little effect. bFGF alone weakly promoted survival (Fig.
5C) and together with insulin promoted the survival a little
further (Fig. 5C). When CPT-cAMP was added, however, bFGF
and GGF2 promoted the survival of ~95 and 65% of cells, respectively (Fig. 5C). CPT-cAMP appeared to act synergistically with
GGF2 and additively with bFGF. Other peptide trophic factors tested, including platelet-derived growth factor (PDGF-AA and -BB),
transforming growth factor (TGF ), members of the TGF family
(BMP2,4,7), sonic hedgehog (SHH), neurotrophin 3 (NT3), NT4,
vascular endothelial growth factor (VEGF), LIF, and CNTF, did not
promote the survival of APCs, even when tested together with CPT-cAMP.
The morphology of the E17 APCs cultured under high-survival conditions
(bFGF, insulin, and CPT-cAMP together) was similar to that in cultures of P1 astrocytes, which nearly entirely consist of type-1 astrocytes (Fig. 5D). These findings show that bFGF, GGF2, and cAMP
elevation collaborate to promote the survival of APCs.
Effects of bFGF and GGF2 on proliferation of astrocyte
precursor cells
To determine what signals induce APCs to proliferate in the
serum-free medium, we next measured their DNA synthesis rates when
cultured for 4 d in B-S serum-free medium containing various peptide trophic factors. We added BrdU (10 µM) to the
culture medium for 2 hr and determined the percentage of cells that
incorporated BrdU into their DNA (see Materials and Methods). When APCs
were cultured in B-S serum-free medium without any factors, the
majority of the cells died. Because these cells were cultured on glass coverslips, on which APCs survive less well compared with survival on
tissue culture plastic, the survival rate was <10%. To enhance survival, we cultured APCs with bFGF for only 1 hr and then switched to
medium lacking peptide factors. We found that such a transient exposure
to bFGF promoted survival but little proliferation. For instance, in
this case >90% of APCs survived for at least 4 d, but <4% of
them were BrdU+ (Fig.
6A). When APCs were
cultured for 4 d with GGF2 or bFGF in the presence of
CPT-cAMP, DNA synthesis increased significantly with 8 and 17% of the
APCs incorporating BrdU, respectively (Fig. 6A; a
17% uptake suggests the APCs are dividing very rapidly, at least once
per day). The elimination of CPT-cAMP from the medium only slightly
decreased these percentages (data not shown), and the combination of
GGF2 and bFGF together did not increase proliferation further. None of
the other peptide trophic factors tested, including SHH, PDGF-AA,
PDGF-BB, TGF , members of the TGF family (BMP2,4,7), NT3, NT4,
VEGF, and CNTF, stimulated proliferation of the APCs. These results
show that APCs have a low spontaneous division rate and need to be
signaled to divide more rapidly.

View larger version (10K):
[in this window]
[in a new window]
|
Figure 6.
Proliferation of astrocyte precursor cells.
A, Purified APCs were cultured in bFGF
for 1 hr, followed by washing and culture in serum-free B-S medium
containing CPT-cAMP and the indicated peptide factors. After 4 d,
the cells were incubated with BrdU for 2 hr and stained
by an anti-BrdU antibody. The percentage of
BrdU+ APCs over total APCs was
counted. The results represent means ± SD of three wells of a
single experiment and were confirmed by at least three separate
experiments. B, Proliferation of astrocyte lineage cells
in vivo is shown. Two hours after an intraperitoneal
injection of BrdU, optic nerves of various ages were
sectioned and stained by a monoclonal anti-BrdU antibody
and a polyclonal anti-Pax2 antiserum. At each age, the percentage of
Pax2+ cells that was also
BrdU+ was determined. The results are
means ± SEM of six sections from three different animals in each
age group.
|
|
To compare directly the in vitro proliferation rate with
that in vivo, we determined the proliferation rates of APCs
and astrocytes in the optic nerve at various ages using a BrdU assay
(see Materials and Methods). We injected BrdU into pregnant (for
E16-E18) and perinatal (for P1, P5, and P8) animals and after 2 hr
killed the animals. The proliferation rates were obtained by double
immunostaining cryosections of the optic nerves from the BrdU-injected
animals or their embryos with the anti-Pax2 antiserum and the anti-BrdU antibody. Figure 6B summarizes the percentage of
Pax2+ astrocyte lineage cells that incorporated BrdU
in optic nerves at various ages. At E16, over 40% of APCs were
BrdU+ (Fig. 6B), but this
percentage dropped quickly during the next 2 d concurrently with
the rapid onset of astrocyte differentiation during that period of time
(Fig. 2). A low level of proliferation persisted after birth, because 5 and 2% of the astrocytes were still BrdU+ at P1 and
P8, respectively. Thus, although astrocytes and APCs divide in
vivo, APCs divide much more rapidly.
Effects of CNTF and LIF on the differentiation of astrocyte
precursor cells
To determine whether the precursor cells would differentiate into
GFAP+ astrocytes by default, we cultured the APCs in
B-S serum-free medium for 4 d and stained with an anti-GFAP
antibody. At the time of plating, only ~8% of the purified E17 APCs
were GFAP+ (see above). After 4 d in culture,
the majority of the cells had died, but most of the surviving cells
were still GFAP . Similarly, when we enhanced the
survival of the APCs by culturing them for 1 hr in bFGF and CPT-cAMP
and then replaced the medium with B-S serum-free medium lacking
peptide trophic factors for 4 d, only ~20% of cells were
GFAP+ (Figs. 7,
8A). Addition of
insulin, CPT-cAMP, bFGF, GGF2, or all of these together did not
significantly increase the amount of astrocyte differentiation further
(data not shown).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7.
Effect of peptide trophic factors on the
differentiation of astrocyte precursor cells. Purified astrocyte
precursor cells were cultured in B-S serum-free medium containing bFGF,
CPT-cAMP, and insulin for 1 hr, subsequently were washed and cultured
in medium containing the indicated factors for 4 d, and then were
immunostained with an anti-GFAP antibody. The data
represent means ± SD of six samples of a single experiment and
were confirmed by three separate experiments.
|
|

View larger version (65K):
[in this window]
[in a new window]
|
Figure 8.
Effects of CNTF and
LIF on the differentiation of astrocyte precursor cells.
A-F, Astrocyte precursor cells were cultured in B-S
serum-free medium containing bFGF, CPT-cAMP, and insulin for 1 hr to
promote their survival and then were changed to a medium lacking
(A, B) or containing CNTF
(C, D) or LIF
(E, F). After 4 d, the cells
were fixed and stained with an anti-GFAP antibody
(A, C, E). Nuclei were
visualized by DAPI staining (B,
D, F). Almost all of the cells
treated with CNTF or LIF were stained by
GFAP antibody. G, H, The
morphology of these cells looked quite similar to that of astrocytes
purified from P1 rat optic nerves. Scale bar, 80 µm.
|
|
We next investigated whether peptide trophic signals normally present
in the nerve could promote the differentiation of APCs into astrocytes.
A number of the factors tested, including BMP2,4,7, PDGF-AA, PDGF-BB,
NT3, NT4, TGF , TGF 1, and SHH, did not significantly promote
astrocyte differentiation. When CNTF or LIF was added to the B-S
serum-free medium, however, most cells died, but nearly all of the
surviving cells became GFAP+. When the cells were
cultured initially for 1 hr with bFGF, insulin, and CPT-cAMP to improve
their survival to almost 100% and subsequently were treated for 4 d with CNTF (Figs. 7, 8C,D) or LIF (Figs.
7, 8E,F), >95% of the
cells differentiated into GFAP+ astrocytes. This
effect of CNTF and LIF to increase the percentage of astrocytes in
these cultures is instructive rather than selective, because in this
experiment nearly all of the cells survived. The morphology of the
differentiated cells was very similar to that of
GFAP+ astrocytes purified from P1 optic nerves (Fig.
8G,H). Taken together, these findings
show that APCs do not differentiate into GFAP+
astrocytes at an appreciable rate unless signaled to do so by extrinsic
signals such as CNTF or LIF.
CNTF only needed to be added to the cultures for 1 hr to induce the
majority of the APCs to differentiate (data not shown). The
differentiation-inducing effect of CNTF was not reversible because when
the APCs were treated with CNTF to induce their differentiation into
astrocytes and then switched to serum-free medium containing bFGF but
lacking CNTF and cultured for several days, GFAP staining was still
present (data not shown).
Effects of mixed optic nerve cells on survival, proliferation, and
differentiation of astrocyte precursor cells
The present findings show that the purified APCs do not survive,
proliferate, or differentiate unless induced to do so by specific
peptide signals known to be produced within the developing optic
nerves. To determine what cell types are controlling APC development,
we cultured the purified E17 APCs above a conditioning layer of mixed
E17 embryonic optic nerve cells (see Materials and Methods).
Approximately 50% of the APCs survived for 3 d (Fig. 9A), compared with only 15%
of cells cultured in the absence of optic nerve cells. To examine
whether optic nerve cells also promoted the proliferation or
differentiation of the APCs, we repeated this experiment but added
insulin and CPT-cAMP to the culture medium to enhance the survival of
the APCs further. After 4 d, ~5% of the APCs were
BrdU+ in cocultures, whereas only 1% of the APCs
were positive in control cocultures lacking optic nerve cells (Fig.
9B). Nearly identical values were obtained when BrdU
incorporation was measured after 2 d of culture. Finally, APCs
were stained by an anti-GFAP antibody after 4 d of culture alone
or in coculture with the mixed optic nerve cells. Over 80% of the APCs
were GFAP+ in coculture, compared with 20% in
control cultures (Fig. 9C). Thus, astrocyte differentiation
occurs in vitro with approximately the same time course that
would have occurred if the APCs had remained in vivo. Taken
together, these findings show that soluble signals from mixed optic
nerve cells strongly promote the survival and differentiation of APCs
and weakly promote their proliferation.

View larger version (15K):
[in this window]
[in a new window]
|
Figure 9.
Effect of mixed optic nerve cells on survival,
proliferation, and differentiation of APCs in culture. APCs were
cocultured above a conditioning layer of E17 mixed optic nerve cells
that had been allowed to condition the medium for 2 d before
addition of the APCs (the cocultures are labeled O.N.
CM). APCs cultured on glass coverslips without optic
nerve cells were used as controls. A, After 4 d of
culture, survival of APCs was determined morphologically.
B, Proliferation of APCs was studied by a
BrdU assay, as described in the text.
C, Differentiation was studied by GFAP
immunostaining. The results represent means ± SD of three samples
and were confirmed by at least one additional experiment.
|
|
RGCs have been reported recently to drive the proliferation of
postnatal astrocytes in the optic nerve, raising the question of
whether they also drive APC proliferation in the embryonic optic nerve.
We thus next cultured the purified E17 APCs for 3 d in direct
contact with, rather than over a conditioning layer of, purified E17
RGCs in the presence of BDNF, insulin, and CPT-cAMP to help promote RGC
survival (Meyer-Franke et al., 1995 ). We allowed direct contact because
of the possibility that bFGF or neuregulin isoforms could be on the
axonal membrane rather than secreted into the medium. Neither the
survival, proliferation, nor differentiation of the APCs was
significantly promoted compared with that of purified APCs cultured in
the same culture medium in the absence of RGCs, even when APCs were
transiently cultured with bFGF to promote their survival. GGF2 together
with optic nerve cells did not stimulate proliferation of APCs over
optic nerve cells or GGF2 alone (data not shown).
 |
DISCUSSION |
Astrocyte precursor cells can be antigenically identified,
purified, and cultured
The purification and culture of progenitor cells have provided a
powerful approach for understanding how their survival, proliferation, and differentiation are controlled. In brain development, just as in
the hematopoietic system, initially multipotent stem cells, capable of
generating many types of neurons and glia, give rise to progressively
more restricted precursor cells. For instance, precursors from
embryonic and postnatal brain that are restricted to generating just
neurons, astrocytes, and oligodendrocytes or just oligodendrocytes have
been identified (Raff et al., 1983 ; Levison and Goldman, 1993 ; Davis
and Temple, 1994 ; Rao and Mayer-Proschel, 1997 ; Qian et al., 1998 ; Shen
et al., 1998 ). Whether or not cells committed to the production of
astrocytes exist has not been clear.
In the present study, we have identified a glial precursor cell present
in large numbers in embryonic rat optic nerve that appears to be
committed to giving rise to astrocytes and not to oligodendrocytes;
whether it could give rise to neurons if placed in environments other
than the optic nerve is not yet clear. A strong case can be made that
the APCs we purified must be the main precursor cells for optic nerve
astrocytes. First, the astrocyte precursors and astrocytes share
several antigens including the Pax2 transcription factor. Second,
virtually all of the neuroepithelial cells isolated from E17 optic
nerve are Pax2+ cells that have the capacity to give
rise to astrocytes in vitro. Third, the numbers of APCs at
E17 appear appropriate to generate rapidly the large number of
astrocytes present in E19 nerves. We typically isolated ~5000 APCs
per E17 nerve, and by E19 there are ~10,000 astrocytes per nerve,
which is reasonably consistent with our finding that the APCs at E17
were dividing at a rate of approximately once per day and that some
glial apoptosis is occurring within the nerve at this stage (B. A. Barres, unpublished observations). Finally, because nearly all
of the neuroepithelial cells in the E17 nerve are APCs, there is no
alternative candidate cell present in sufficient number to give rise to
so many astrocytes by E19.
The APCs that we identified, purified, and cultured are thus the
precursor cells for fibrous astrocytes within the optic nerve, as
originally suggested by Martin Raff et al. (1984 ). Whether these cells
are similar to other types of astrocyte precursors within the brain or
have the capability to generate other types of astrocytes will be
addressed in future studies. In any case, the ability to purify and
culture these cells should allow further elucidation of the intrinsic
and extrinsic signaling mechanisms that normally control the
development of these cells within the optic nerve.
Pax2 is a specific astrocyte lineage marker in optic nerve
The present studies show that in the developing optic nerve, the
paired-box transcription factor Pax2 is a specific marker of astrocyte
lineage cells, with nuclear immunoreactivity found in all astrocytes
and their precursors but not in oligodendrocyte lineage cells,
microglial cells, endothelial cells, or meningeal cells. The APCs could
be distinguished from astrocytes by the additional presence of other
antigens in the astrocytes including GFAP and S100 . Interestingly,
as has been reported for all other glial precursor cells identified to
date in the rat brain, the APCs stained on their surfaces with the A2B5 antibody.
During normal development, optic nerve axons interact tightly with the
optic stalk cells, which in turn differentiate into glial cells
(Horsburgh and Sefton, 1986 ). Pax2 is required for patterning in the
optic stalk because transgenic mice lacking Pax2 have defective closure
of the optic fissure, defective establishment of axonal pathways along
the optic stalk, few optic nerve glia, and agenesis of the optic chiasm
(Torres et al., 1996 ; Macdonald et al., 1997 ). The lack of optic nerve
glia in the Pax2-deficient mice, together with the presence of Pax2 in
nearly all astrocytes and APCs, suggests that Pax2 plays a
crucial role in determining the APC fate.
Is Pax2 a marker of other types of astrocytes, such as fibrous
astrocytes in other white matter pathways in the brain? Pax2 was not
expressed by astrocytes in the optic chiasm (this paper), and in
preliminary experiments it was also not expressed by astrocytes in the
corpus callosum (our unpublished observations). Thus although optic
nerve astrocytes have many similarities to fibrous astrocytes in other
brain regions, they have clear antigenic differences such as the
expression of Pax2 as well as the RAN-2 antigen, which is also not
present on astrocytes in the optic chiasm or corpus callosum (Barres,
unpublished observations). This is not surprising because regional
astrocyte heterogeneity has been documented frequently before.
APCs must be signaled by other cell types to survive
and proliferate
We found that purified APCs quickly died in serum-free culture but
could be saved and induced to proliferate by bFGF, by GGF2, or by
medium conditioned by other embryonic optic nerve cell types. In
contrast, purified optic nerve astrocytes, when cultured at similar
density, survived and proliferated in the absence of added signals,
although at low density they died and did not proliferate. These
findings suggest that although to some extent astrocytes are able to
produce signals that help to promote their own survival and
proliferation, APCs cannot, raising the question of which cell types
normally signal the APCs to survive and divide.
Developing retinal ganglion cells produce both bFGF and neuregulins
including GGF2 (de Iongh and McAvoy, 1992 ; Shi et al., 1998 ),
and RGC axons strongly stimulate the development of APCs in the
developing optic nerve (Silver and Robb, 1979 ; Horsburgh and Sefton,
1986 ), raising the question of whether RGCs may normally help to
stimulate the survival and proliferation of APCs. A similar role for
axon-derived neuregulins, which stimulate Schwann cell survival,
proliferation, and differentiation in vitro, has recently been demonstrated for Schwann cell development in vivo
(Riethmacher et al., 1997 ), and it has been shown that optic nerve
axons drive the proliferation of astrocytes in the postnatal optic
nerve (Burne and Raff, 1997 ). They showed that astrocyte proliferation
in postnatal nerves nearly ceased after optic nerve transection and
that in culture studies retinal ganglion cells stimulated astrocyte
division. This effect was mimicked by addition of bFGF but not GGF2. To date our data do not provide any direct support for the possibility that embryonic RGCs drive the development of APCs because we failed to
detect a promotion of APC survival, proliferation, or differentiation when they were cultured together with embryonic RGCs. It is possible, however, that the embryonic RGCs in culture behave differently than
they do in vivo.
In contrast, survival and proliferation of the APCs were significantly
stimulated by embryonic optic nerve cells. The main cell types in the
embryonic optic nerve, other than the APCs themselves, include pial
cells and vascular endothelial cells. Because astrocytes make extensive
contacts with both pial cells and blood vessels (Suarez and Raff, 1989 ;
Peters et al., 1991 ), it would make some sense for either or both cell
types to help promote APC survival or proliferation (see below).
Differentiation of APCs into astrocytes does not occur by default
but requires extrinsic signals
Committed oligodendrocyte precursor cells generate
oligodendrocytes in culture by default without the need for any
specific inducing signals when their mitogens are withdrawn (Raff et
al., 1983 ; Barres et al., 1994 ). In contrast, we found that optic nerve astrocyte precursor cells do not differentiate in culture, even when
they are not dividing, unless they are induced to differentiate by a
specific signal. The two signals that we have identified to date that
induce their differentiation are CNTF and LIF. Both cytokines have been
suggested previously to induce multipotent neural stem cells in culture
to give rise to astrocytes (Johe et al., 1996 ; Bonni et al., 1997 ),
although, because purified populations of stem cells were not studied,
the possibility that CNTF and LIF acted on a more restricted precursor
cell could not be completely excluded. The present studies show clearly
that the action of CNTF and LIF in inducing astrocytes is instructive and not selective because these two signals do not promote the survival
of either the astrocyte precursor cells or the astrocytes.
Do CNTF or LIF normally induce astrocyte differentiation in the
developing optic nerve? CNTF is almost certainly not involved because
it is expressed in the optic nerve only postnatally, whereas most of
the APCs differentiate into astrocytes embryonically (Stockli et al.,
1991 ). In addition, in contrast to LIF, CNTF lacks a secretory signal
sequence, and there is not yet any convincing evidence that it is
normally secreted. LIF, however, is an excellent candidate. When the
LIF receptor is mutated, there is a marked decrease in both GFAP
expression and astrocyte generation in culture and in vivo
(Ware et al., 1995 ; Koblar et al., 1998 ), and in preliminary experiments we have found that LIF mRNA is expressed by non-neural cells in the embryonic optic nerve (our unpublished observations).
Finally, our findings raise the question of which cell type signals the
APCs to differentiate into astrocytes in the optic nerve. The
differentiation of the APCs into astrocytes occurs primarily on E18 and
E19, long after axons have traversed the optic nerve, suggesting that
axons probably do not play a crucial role. Our studies show that
embryonic optic nerve cell types other than APCs, which primarily
consist of pial cells and vascular endothelial cells, secrete an
activity that is sufficient to induce most of the APCs to differentiate
into astrocytes. Because astrocytes contact both pial cells and
endothelial cells, either cell type could be the source of the inducing
activity. Endothelial cells are a particularly plausible candidate for
several reasons. First, endothelial cells in the optic nerve and brain
are closely surrounded by astrocyte processes (Peters et al., 1991 ).
Second, there is a good temporal correlation in the developing brain
between the contact of blood vessels by glial precursor cells and the
expression of GFAP by these cells (Zerlin and Goldman, 1997 ). Third,
the differentiation of astrocytes in the optic nerve is both temporally correlated with its vascularization in late embryonic development and
spatially correlated as astrocytes develop in an outside-to-inside sequence correlating with the outside-to-inside vascularization of
nervous tissue. Taken together, these findings suggest that non-neural
cell types within the optic nerve, either endothelial cells or pial
cells, play an important role in controlling astrocyte generation
during optic nerve development. Because it is now possible to purify
and culture the astrocyte precursor cells, it should be straightforward
in future studies to test this hypothesis directly.
 |
FOOTNOTES |
Received Sept. 25, 1998; revised Nov. 6, 1998; accepted Nov. 10, 1998.
This work was supported by National Eye Institute Grant R29 EY10257 to
B.A.B., National Multiple Sclerosis Society Grant RG2553 to B.A.B, and
National Institutes of Health National Research Service Award
5F32NS10015 to H.M. We thank Cambridge Neuroscience for recombinant
human GGF2, Jim Cohen for C5 neuroepithelial cell antibody, Ursula
Drager for R5 anti-vimentin antibody, and Stephanie Sapperstein and
Songli Wang for helpful comments on this manuscript.
Correspondence should be addressed to Dr. Ben A. Barres, Stanford
University School of Medicine, Department of Neurobiology, Fairchild
Science Building D235, Stanford, CA 94305-5125.
 |
REFERENCES |
-
Barres BA,
Raff MC
(1994)
Control of oligodendrocyte number in the developing rat optic nerve.
Neuron
12:935-942[Web of Science][Medline].
-
Barres BA,
Hart IK,
Coles HS,
Burne JF,
Voyvodic JT,
Richardson WD,
Raff MC
(1992)
Cell death and control of cell survival in the oligodendrocyte lineage.
Cell
70:31-46[Web of Science][Medline].
-
Barres BA,
Schmid R,
Sendnter M,
Raff MC
(1993)
Multiple extracellular signals are required for long-term oligodendrocyte survival.
Development
118:283-295[Abstract].
-
Barres BA,
Raff MC,
Gaese F,
Bartke I,
Dechant G,
Barde YA
(1994)
A crucial role for neurotrophin-3 in oligodendrocyte development.
Nature
367:371-375[Medline].
-
Bartlett PF,
Noble MD,
Pruss RM,
Raff MC,
Rattray S,
Williams CA
(1980)
Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Muller cells and lepto-meninges defined by a monoclonal antibody.
Brain Res
204:339-351.
-
Bonni A,
Sun Y,
Nadal-Vicens M,
Bhatt A,
Frank DA,
Rozovsky I,
Stahl N,
Yancopoulos GD,
Greenberg ME
(1997)
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.
Science
278:477-483[Abstract/Free Full Text].
-
Bottenstein JE,
Sato GH
(1979)
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Proc Natl Acad Sci USA
76:514-517[Abstract/Free Full Text].
-
Burne JF,
Raff MC
(1997)
Retinal ganglion cell axons drive the proliferation of astrocytes in the developing rodent optic nerve.
Neuron
18:223-230[Web of Science][Medline].
-
Choi BH,
Lapham LW
(1978)
Radial glia in the human fetal cerebrum: a combined Golgi, immunofluorescent and electron microscopic study.
Brain Res
148:295-311[Web of Science][Medline].
-
Davis AA,
Temple S
(1994)
A self renewing multipotential stem cell in the embryonic rat cerebral cortex.
Nature
372:263-266[Medline].
-
de Iongh R,
McAvoy JW
(1992)
Distribution of acidic and basic fibroblast growth factors in the fetal rat eye.
Growth Factors
6:159-177[Medline].
-
Drager UC,
Edwards DL,
Barnstable CJ
(1984)
Antibodies against filamentous components in discrete cell types of the mouse retina.
J Neurosci
4:2025-2042[Abstract].
-
Fok-Seang J,
Miller RH
(1992)
Astrocyte precursors in neonatal rat spinal cord cultures.
J Neurosci
12:2751-2764[Abstract].
-
Frederiksen K,
McKay RD
(1988)
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo.
J Neurosci
8:1144-1151[Abstract].
-
Fulton BP,
Burne JF,
Raff MC
(1992)
Visualization of O-2A progenitor cells in the developing and adult rat optic nerve by quisqualate-stimulated cobalt uptake.
J Neurosci
12:4816-4833[Abstract].
-
Goldman JE
(1996)
Developmental origins of astrocytes.
In: Glial cell development (Jessen KR,
Richardson WD,
eds), p 31. Oxford: BIOS Scientific.
-
Gross RE,
Mehler MF,
Mabie PC,
Zang Z,
Santschi L,
Kessler JA
(1996)
Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells.
Neuron
17:595-606[Web of Science][Medline].
-
Horsburgh GM,
Sefton AJ
(1986)
The early development of the optic nerve of the rat.
J Comp Neurol
243:547-560[Web of Science][Medline].
-
Hughes SM,
Lillien LE,
Raff MC,
Rohrer H,
Sendtner M
(1988)
Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture.
Nature
335:70-73[Medline].
-
Jessen KR,
Mirsky R
(1997)
Embryonic Schwann cell development: the biology of Schwann cell precursors and early Schwann cells.
J Anat
191:501-505.
-
Johe KK,
Hazel TG,
Muller T,
Dugich-Djordjevic MM,
McKay RD
(1996)
Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.
Genes Dev
10:3129-3140[Abstract/Free Full Text].
-
Koblar SA,
Turnley AM,
Classon BJ,
Reid KL,
Ware CB,
Cheema SS,
Murphy M,
Bartlett PF
(1998)
Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor.
Proc Natl Acad Sci USA
95:3178-3181[Abstract/Free Full Text].
-
Levison SW,
Goldman JE
(1993)
Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain.
Neuron
10:201-212[Web of Science][Medline].
-
Lillien LE,
Sendtner M,
Rohrer H,
Hughes SM,
Raff MC
(1988)
Type-2 astrocyte development in rat brain cultures is initiated by a CNTF-like protein produced by type-1 astrocytes.
Neuron
1:485-494[Web of Science][Medline].
-
Lillien LE,
Sendtner M,
Raff MC
(1990)
Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development.
J Cell Biol
111:635-644[Abstract/Free Full Text].
-
Macdonald R,
Scholes J,
Strahle U,
Brennan C,
Holder N,
Brand M,
Wilson SW
(1997)
The Pax protein Noi is required for commissural axon pathway formation in the rostral forebrain.
Development
124:2397-2408[Abstract].
-
Meyer-Franke A,
Kaplan MR,
Pfrieger FW,
Barres BA
(1995)
Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture.
Neuron
15:805-819[Web of Science][Medline].
-
Miller RH,
Williams BP,
Cohen J,
Raff MC
(1984)
A4: an antigenic marker of neural tube-derived cells.
J Neurocytol
13:329-338[Web of Science][Medline].
-
Miller RH,
David S,
Patel R,
Abney ER,
Raff MC
(1985)
A quantitative immunohistochemical study of macroglial cell development in the rat optic nerve: in vivo evidence for two distinct glial lineages.
Dev Biol
111:35-41[Web of Science][Medline].
-
Miller RH,
ffrench-Constant C,
Raff MC
(1989)
The macroglial cells of the rat optic nerve.
Annu Rev Neurosci
12:517-534[Web of Science][Medline].
-
Misson JP,
Edwards MA,
Yamamoto M,
Caviness Jr VS
(1988)
Identification of radial glial cells within the developing murine central nervous system: studies based upon a new immunohistochemical marker.
Dev Brain Res
44:95-108[Medline].
-
Mosmann T
(1983)
Rapid colorimetric assay for cellular growth and survival.
J Immunol Methods
65:55-63[Web of Science][Medline].
-
Nornes HO,
Dressler GR,
Knapik EW,
Deutsch U,
Gruss P
(1990)
Spatially and temporally restricted expression of Pax2 during murine neurogenesis.
Development
109:797-809[Abstract/Free Full Text].
-
Peters A,
Palay SL,
Webster HF
(1991)
In: The fine structure of the nervous system. New York: Oxford UP.
-
Qian X,
Davis AA,
Goderie SK,
Temple S
(1997)
FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells.
Neuron
18:81-93[Web of Science][Medline].
-
Qian X,
Goderie SK,
Shen Q,
Stern JH,
Temple S
(1998)
Intrinsic programs of patterned cell lineages in isolated vertebrate CNS ventricular zone cells.
Development
125:3143-3152[Abstract].
-
Raff MC
(1989)
Glial cell diversification in the rat optic nerve.
Science
243:1450-1455[Abstract/Free Full Text].
-
Raff MC,
Miller RH,
Noble M
(1983)
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.
Nature
303:390-396[Medline].
-
Raff MC,
Abney ER,
Miller RH
(1984)
Two glial cell lineages diverge prenatally in rat optic nerve.
Dev Biol
106:53-60[Web of Science][Medline].
-
Rao MS,
Mayer-Proschel M
(1997)
Glial-restricted precursors are derived from multipotent neuroepithelial stem cells.
Dev Biol
188:48-63[Web of Science][Medline].
-
Riethmacher D,
Sonnenberg-Reithmacher E,
Brinkmann V,
Yamaai T,
Lewin GR,
Birchmeier C
(1997)
Severe neuropathies in mice with targetted mutations in the ErbB3 receptor.
Nature
389:725-730[Medline].
-
Schmechel DE,
Rakic P
(1979)
A Golgi study of radial glial cells in developing monkey telencephalon: morphogenesis and transformation into astrocytes.
Anat Embryol (Berl)
156:115-152[Medline].
-
Shen Q,
Qian X,
Capela A,
Temple S
(1998)
Stem cells in the embryonic cerebral cortex: their role in histogenesis and patterning.
J Neurobiol
36:162-174[Web of Science][Medline].
-
Shi J,
Marinovich A,
Barres BA
(1998)
Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve.
J Neurosci
18:4627-4636[Abstract/Free Full Text].
-
Silver J,
Robb R
(1979)
Studies on the development of the eye cup and optic nerve in normal mice and in mutants with congenital optic nerve aplasia.
Dev Biol
68:175-190[Web of Science][Medline].
-
Skoff RP
(1990)
Gliogenesis in rat optic nerve: astrocytes are generated in a single wave before oligodendrocytes.
Dev Biol
139:149-168[Web of Science][Medline].
-
Small RK,
Riddle P,
Noble M
(1987)
Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve.
Nature
328:155-157[Medline].
-
Stockli KA,
Lillien LE,
Nahernoe M,
Breitfeld G,
Hughes RA,
Raff MC,
Thoenen H,
Sendtner M
(1991)
Regional distribution, developmental changes, and cellular localization of CNTF mRNA and protein in the rat brain.
J Cell Biol
115:447-459[Abstract/Free Full Text].
-
Suarez I,
Raff MC
(1989)
Subpial and perivascular astrocytes associated with nodes of Ranvier in the rat optic nerve.
J Neurocytol
18:577-582[Web of Science][Medline].
-
Torres M,
Gomez-Pardo E,
Gruss P
(1996)
Pax2 contributes to inner ear patterning and optic nerve trajectory.
Development
122:3381-3391[Abstract].
-
Voigt T
(1989)
Development of glial cells in the cerebral wall of ferrets: direct tracing of their transformation from radial glia into astrocytes.
J Comp Neurol
289:74-88[Web of Science][Medline].
-
Ware CB,
Horowitz MC,
Renshaw BR,
Hunt JS,
Liggitt D,
Koblar SA,
Gliniak BC,
McKenna HJ,
Papayannopoulou T,
Thoma B,
Cheng L,
Donovan PJ,
Preschon JJ,
Bartlett PF,
Willis CR,
Wright BD,
Carpenter MK,
Davison BL,
Gearing DP
(1995)
Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
Development
121:1283-1299[Abstract].
-
Zerlin M,
Goldman JE
(1997)
Interactions between glial progenitors and blood vessels during early postnatal corticogenesis: blood vessel contact represents an early stage of astrocyte differentiation.
J Comp Neurol
387:537-546[Web of Science][Medline].
-
Zerlin M,
Levison SW,
Goldman JE
(1995)
Early patterns of migration, morphogenesis, and intermediate filament expression of subventricular zone cells in the postnatal rat forebrain.
J Neurosci
15:7238-7249[Abstract].
Copyright © 1999 Society for Neuroscience 0270-6474/99/1931049-13$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Barker, S. M. Koch, J. Reed, B. A. Barres, and E. M. Ullian
Developmental Control of Synaptic Receptivity
J. Neurosci.,
August 13, 2008;
28(33):
8150 - 8160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chatzopoulou, A. Miguez, M. Savvaki, G. Levasseur, A. Muzerelle, M.-P. Muriel, O. Goureau, K. Watanabe, L. Goutebroze, P. Gaspar, et al.
Structural Requirement of TAG-1 for Retinal Ganglion Cell Axons and Myelin in the Mouse Optic Nerve
J. Neurosci.,
July 23, 2008;
28(30):
7624 - 7636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Herrmann, T. Imura, B. Song, J. Qi, Y. Ao, T. K. Nguyen, R. A. Korsak, K. Takeda, S. Akira, and M. V. Sofroniew
STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
J. Neurosci.,
July 9, 2008;
28(28):
7231 - 7243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Mo, A. R. Moore, R. Filipovic, Y. Ogawa, I. Kazuhiro, S. D. Antic, and N. Zecevic
Human Cortical Neurons Originate from Radial Glia and Neuron-Restricted Progenitors
J. Neurosci.,
April 11, 2007;
27(15):
4132 - 4145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tezel, X. Yang, C. Luo, Y. Peng, S. L. Sun, and D. Sun
Mechanisms of Immune System Activation in Glaucoma: Oxidative Stress-Stimulated Antigen Presentation by the Retina and Optic Nerve Head Glia
Invest. Ophthalmol. Vis. Sci.,
February 1, 2007;
48(2):
705 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhu, T. Harada, L. Liu, M. E. Lush, F. Guignard, C. Harada, D. K. Burns, M. L. Bajenaru, D. H. Gutmann, and L. F. Parada
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation
Development,
December 15, 2005;
132(24):
5577 - 5588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Evans and P. J. Gage
Expression of the homeobox gene Pitx2 in neural crest is required for optic stalk and ocular anterior segment development
Hum. Mol. Genet.,
November 15, 2005;
14(22):
3347 - 3359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Scheffler, N. M. Walton, D. D. Lin, A. K. Goetz, G. Enikolopov, S. N. Roper, and D. A. Steindler
Phenotypic and functional characterization of adult brain neuropoiesis
PNAS,
June 28, 2005;
102(26):
9353 - 9358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Mui, J. W. Kim, G. Lemke, and S. Bertuzzi
Vax genes ventralize the embryonic eye
Genes & Dev.,
May 15, 2005;
19(10):
1249 - 1259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. De Seranno, C. Estrella, A. Loyens, A. Cornea, S. R. Ojeda, J.-C. Beauvillain, and V. Prevot
Vascular Endothelial Cells Promote Acute Plasticity in Ependymoglial Cells of the Neuroendocrine Brain
J. Neurosci.,
November 17, 2004;
24(46):
10353 - 10363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyawaki, A. Uemura, M. Dezawa, R. T. Yu, C. Ide, S. Nishikawa, Y. Honda, Y. Tanabe, and T. Tanabe
Tlx, an Orphan Nuclear Receptor, Regulates Cell Numbers and Astrocyte Development in the Developing Retina
J. Neurosci.,
September 15, 2004;
24(37):
8124 - 8134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Chan-Ling, D. S. McLeod, S. Hughes, L. Baxter, Y. Chu, T. Hasegawa, and G. A. Lutty
Astrocyte-Endothelial Cell Relationships during Human Retinal Vascular Development
Invest. Ophthalmol. Vis. Sci.,
June 1, 2004;
45(6):
2020 - 2032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yang, O. Agapova, A. Parker, W. Shannon, P. Pecen, J. Duncan, M. Salvador-Silva, and M. R. Hernandez
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure
Physiol Genomics,
April 13, 2004;
17(2):
157 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Okano-Uchida, T. Himi, Y. Komiya, and Y. Ishizaki
Cerebellar granule cell precursors can differentiate into astroglial cells
PNAS,
February 3, 2004;
101(5):
1211 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Lo, L. L. Rowlette, M. Caballero, P. Yang, M. R. Hernandez, and T. Borras
Tissue Differential Microarray Analysis of Dexamethasone Induction Reveals Potential Mechanisms of Steroid Glaucoma
Invest. Ophthalmol. Vis. Sci.,
February 1, 2003;
44(2):
473 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Spassky, F. de Castro, B. Le Bras, K. Heydon, F. Queraud-LeSaux, E. Bloch-Gallego, A. Chedotal, B. Zalc, and J.-L. Thomas
Directional Guidance of Oligodendroglial Migration by Class 3 Semaphorins and Netrin-1
J. Neurosci.,
July 15, 2002;
22(14):
5992 - 6004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Moon, J.-Y. Yoo, V. Matarazzo, Y. K. Sung, E. J. Kim, and G. V. Ronnett
Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation
PNAS,
June 25, 2002;
99(13):
9015 - 9020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Goldberg, M. P. Klassen, Y. Hua, and B. A. Barres
Amacrine-Signaled Loss of Intrinsic Axon Growth Ability by Retinal Ganglion Cells
Science,
June 7, 2002;
296(5574):
1860 - 1864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gregori, C. Proschel, M. Noble, and M. Mayer-Proschel
The Tripotential Glial-Restricted Precursor (GRP) Cell and Glial Development in the Spinal Cord: Generation of Bipotential Oligodendrocyte-Type-2 Astrocyte Progenitor Cells and Dorsal-Ventral Differences in GRP Cell Function
J. Neurosci.,
January 1, 2002;
22(1):
248 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Morrow, M.-R. Song, and A. Ghosh
Sequential specification of neurons and glia by developmentally regulated extracellular factors
Development,
September 15, 2001;
128(18):
3585 - 3594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mi, H. Haeberle, and B. A. Barres
Induction of Astrocyte Differentiation by Endothelial Cells
J. Neurosci.,
March 1, 2001;
21(5):
1538 - 1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bertuzzi, R. Hindges, S. H. Mui, D. D.M. O'Leary, and G. Lemke
The homeodomain protein Vax1 is required for axon guidance and major tract formation in the developing forebrain
Genes & Dev.,
December 1, 1999;
13(23):
3092 - 3105.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. F. McManus, L.-C. Chen, I. Vallejo, and M. Vallejo
Astroglial Differentiation of Cortical Precursor Cells Triggered by Activation of the cAMP-Dependent Signaling Pathway
J. Neurosci.,
October 15, 1999;
19(20):
9004 - 9015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Wallace and M. Raff
A role for Sonic hedgehog in axon-to-astrocyte signalling in the rodent optic nerve
Development,
January 7, 1999;
126(13):
2901 - 2909.
[Abstract]
[PDF]
|
 |
|
|